Berberine inhibits human tongue squamous carcinoma cancer tumor growth in a murine xenograft model

ASIA unversity > 醫學暨健康學院 > 生物科技學系 > 期刊論文 > Item 310904400/8255

Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/8255

Title:	Berberine inhibits human tongue squamous carcinoma cancer tumor growth in a murine xenograft model
Authors:	Ho, YT (Ho, Yung-Tsuan);Yang, JS (Yang, Jai-Sing);Lu, CC (Lu, Chi-Cheng);Chiang, JH (Chiang, Jo-Hua);Li, TC (Li, Tsai-Chung);Lin, JJ (Lin, Jen-Jyh);Lai, KC (Lai, Kuang-Chi);Liao, CL (Liao, Ching-Lung);Lin, JG (Lin, Jaung-Geng);Chung, JG (Chung, Jing-Gung)
Contributors:	Department of Biotechnology
Keywords:	Berberine;Human tongue SCC-4 cancer cells;Xenograft transplantation;In vivo
Date:	2009-09
Issue Date:	2010-03-26 02:29:22 (UTC+0)
Publisher:	Asia University
Abstract:	Our primary studies showed that berberine induced apoptosis in human tongue cancer SCC-4 cells in vitro. But there is no report to show berberine inhibited SCC-4 cancer cells in vivo on a murine xenograft animal model. SCC-4 tumor cells were implanted into mice and groups of mice were treated with vehicle, berberine (10 mg/kg of body weight) and doxorubicin (4 mg/kg of body weight). The tested agents were injected once per four days intraperitoneally (i.p.), with treatment starting 4 weeks prior to cells inoculation. Treatment with 4 mg/kg of doxorubicin or with 10 mg/kg of berberine resulted in a reduction in tumor incidence. Tumor size in xenograft mice treated with 10 mg/kg berberine was significantly smaller than that in the control group. Our findings indicated that berbeirne inhibits tumor growth in a xenograft animal model. Therefore, berberine may represent a tongue cancer preventive agent and can be used in clinic. (c) 2009 Elsevier GmbH. All rights reserved.
Relation:	PHYTOMEDICINE 16 (9): 887-890
Appears in Collections:	[生物科技學系] 期刊論文

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	548	View/Open
150.doc		37Kb	Microsoft Word	329	View/Open

Loading...